- Home
- ARMP vs SATL Comparison
ARMP vs SATL Comparison
Compare ARMP & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- SATL
- Stock Information
- Founded
- ARMP N/A
- SATL 2010
- Country
- ARMP United States
- SATL Uruguay
- Employees
- ARMP N/A
- SATL N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- SATL Radio And Television Broadcasting And Communications Equipment
- Sector
- ARMP Health Care
- SATL Technology
- Exchange
- ARMP Nasdaq
- SATL Nasdaq
- Market Cap
- ARMP 80.0M
- SATL 95.7M
- IPO Year
- ARMP N/A
- SATL N/A
- Fundamental
- Price
- ARMP $1.98
- SATL $3.60
- Analyst Decision
- ARMP Strong Buy
- SATL
- Analyst Count
- ARMP 1
- SATL 0
- Target Price
- ARMP $7.00
- SATL N/A
- AVG Volume (30 Days)
- ARMP 9.2K
- SATL 1.7M
- Earning Date
- ARMP 11-13-2024
- SATL 12-24-2024
- Dividend Yield
- ARMP N/A
- SATL N/A
- EPS Growth
- ARMP N/A
- SATL N/A
- EPS
- ARMP N/A
- SATL N/A
- Revenue
- ARMP $5,467,000.00
- SATL $13,719,000.00
- Revenue This Year
- ARMP N/A
- SATL N/A
- Revenue Next Year
- ARMP $83.33
- SATL N/A
- P/E Ratio
- ARMP N/A
- SATL N/A
- Revenue Growth
- ARMP 34.92
- SATL 101.51
- 52 Week Low
- ARMP $1.97
- SATL $0.72
- 52 Week High
- ARMP $4.48
- SATL $5.49
- Technical
- Relative Strength Index (RSI)
- ARMP 38.26
- SATL 63.31
- Support Level
- ARMP $1.97
- SATL $3.10
- Resistance Level
- ARMP $2.30
- SATL $4.16
- Average True Range (ATR)
- ARMP 0.11
- SATL 0.62
- MACD
- ARMP -0.02
- SATL 0.05
- Stochastic Oscillator
- ARMP 7.50
- SATL 53.32
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.